Michael Carney, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 116 Mayfield Dr, Campbellsville, KY 42718 Phone: 270-932-2264 |
Michael Atcher, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1700 Old Lebanon Rd, Campbellsville, KY 42718 Phone: 270-465-3561 |
Andrew Hancock, CRNA Nurse Anesthetist, Certified Registered Medicare: May Accept Medicare Assignments Practice Location: 1700 Old Lebanon Rd, Campbellsville, KY 42718 Phone: 270-932-3694 Fax: 334-395-4110 |
Ms. Nicole Marie Juhasz, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1700 Old Lebanon Rd, Campbellsville, KY 42718 Phone: 270-932-3694 Fax: 270-932-2154 |
Mrs. Kirsten L Ashby, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1700 Old Lebanon Road, Campbellsville, KY 42718 Phone: 270-932-3694 Fax: 270-932-2154 |
Jennifer Carole Boils, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1700 Old Lebanon Rd, Campbellsville, KY 42718 Phone: 270-465-3561 |
News Archive
Researchers at Dana-Farber Cancer Institute have received a $5.6 million grant from the Defense Advanced Research Projects Agency (DARPA) and the Army Research Office (ARO) to develop transient immunity against known, unknown, naturally occurring, or engineered disease-causing pathogens. The ultimate goal is to develop a viable countermeasure to an unknown pathogen within seven days of receiving it in a laboratory.
In follow-up coverage of the WHO's announcement Wednesday of a plan to contain the spread of artemisinin-resistant malaria, news outlets examined the scope of the problem, reactions to the plan and speculations of how the anticipated $175 million annual cost would be funded.
Attorneys general from six states will sit in the Supreme Court to hear the oral arguments over the health reform law. In the meantime, Pennsylvania lawmakers may offer a constitutional amendment to ban laws mandating people have health insurance.
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% as a twice-daily prescription eye drop treatment for ocular itching associated with allergic conjunctivitis in patients two years of age and older.
› Verified 6 days ago